Labcorp

Dan's routine colonoscopy revealed over 100 polyps, which are growths that can develop into cancer. His experience led to a rare genetic diagnosis and inspired advocacy for colorectal cancer screening and hereditary cancer research. Colorectal cancer is one of the only cancers that can be prevented through screening. Learn more about Dan's story: https://spr.ly/6046FD1cs #ColorectalCancerAwarenessMonth #CRCAwareness

We are honored?to join the AMP Parkinson's Disease and Related Disorders (AMP PDRD) initiative to enable earlier diagnoses, inform breakthrough therapies, and, ultimately, help change the course of Parkinson’s Disease and related disorders worldwide.?

Attending the AAN Annual Meeting in San Diego? Don't miss Dr. John Winslow's presentation on the use of the pTau217/Aβ42 Ratio test for Alzheimer's disease. Learn more: https://spr.ly/60400AG4a

The path to an autoimmune disorder diagnosis can take an average of 4.5 years and four doctor visits. But what if there was a way to change that? At Labcorp, our comprehensive autoimmune testing portfolio can help provide clarity. From aiding initial diagnosis to monitoring disease progression and guiding treatment plans, our solutions are designed to support your goal of improving outcomes for patients impacted by these complex conditions. Browse our comprehensive test portfolio: https://spr.ly/60440sp0G #AutoimmuneDisorders #AutoimmuneAwarenessMonth

Oral fluid drug testing is gaining momentum in workplace drug testing. Dr. Lance Presley, PhD, FABFT, shares why companies are embracing this faster and less invasive approach. Learn more: https://spr.ly/60470mQdd #DrugTesting #DrugScreening

Despite a rise in colorectal cancer (CRC) cases—especially among people younger than 50—screening rates remain low. CRC is highly treatable when caught early, but it often has no symptoms in its early stages. Screening can detect and remove precancerous polyps before they turn into cancer, helping to prevent CRC altogether. Learn more: https://spr.ly/60440dMQK #CRCAwareness #ColorectalCancerAwarenessMonth

Heading to #SHRMTalent? Leaders from Labcorp and the largest academic health system in New Jersey will be on-site to discuss reducing onboarding time and solving staffing challenges. Learn more about the discussion: https://spr.ly/60420VyNo #SHRMTalent #Onboarding #Staffing #SHRM #HR #humanresources

With no single test to diagnose multiple sclerosis (MS), MS diagnosis and patient management remain challenging. This Multiple Sclerosis Awareness Week, we want to raise awareness of those living with MS and support the providers helping to manage their care. To help providers develop precise management strategies for MS, Labcorp offers the Multiple Sclerosis Monitoring Profile, which combines two powerful biomarkers: NfL and GFAP. Learn how our extensive portfolio of MS tests can help providers and their patients: https://spr.ly/60430M2O5 #MultipleSclerosis

A warm welcome to our 30 new India interns at Labcorp! These students from universities across India are kick-starting their careers in project management, clinical research, immunology and immunotoxicology, specimen solutions and IT. We look forward to learning from their perspectives and supporting their growth as we work together to improve health and improve lives around the world. Interested in an internship with Labcorp? Learn more here: https://spr.ly/6047I9R4S #JoinThePursuit #EarlyCareers #Internships

Today, we entered into an agreement to acquire select assets of BioReference Health, a wholly owned subsidiary of OPKO Health. Through this transaction, we will acquire BioReference Health’s laboratory testing businesses focused on oncology and oncology-related clinical testing services across the United States. Read the full announcement here: https://spr.ly/60470y18f BioReference #Oncology #ClinicalDrugTesting